Tyra Biosciences Ownership 2024 | Who Owns Tyra Biosciences Now?


OverviewForecastRevenueFinancialsChart

Institutional Ownership

17.76%

Insider Ownership

5.33%

Retail Ownership

76.90%

Institutional Holders

25.00

Tyra Biosciences Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
RA CAPITAL MANAGEMENT, L.P.24.24%0.25%10,416,6093,180,15543.95%170,832,388Mar 31, 2024
BOXER CAPITAL, LLC15.01%5.22%6,448,359--105,753,088Mar 31, 2024
BVF INC/IL10.85%2.10%4,661,1941,921,59970.14%76,443,582Mar 31, 2024
CANAAN PARTNERS XI LLC10.26%79.77%4,409,991--72,323,852Mar 31, 2024
NEXTECH INVEST LTD.9.44%10.54%4,055,8611,537,27961.04%66,516,120Mar 31, 2024
FMR LLC9.26%0.00%3,977,2081,208,51243.65%65,226,211Mar 31, 2024
TCG CROSSOVER MANAGEMENT, LLC4.63%2.58%1,989,103--32,621,289Mar 31, 2024
FAIRMOUNT FUNDS MANAGEMENT LLC3.24%2.49%1,393,329--22,850,596Mar 31, 2024
BLACKROCK INC.2.43%0.00%1,044,22579,1918.21%17,125,289Mar 31, 2024
5AM VENTURE MANAGEMENT, LLC2.19%3.45%939,298384,31969.25%15,404,487Mar 31, 2024
VANGUARD GROUP INC2.09%0.00%899,800140,83318.56%14,756,720Mar 31, 2024
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.1.94%0.58%832,220-194,200-18.92%13,648,408Mar 31, 2024
ORBIMED ADVISORS LLC1.79%0.23%768,638768,638100.00%12,605,663Mar 31, 2024
PERCEPTIVE ADVISORS LLC1.56%0.19%669,159309,15985.88%10,974,208Mar 31, 2024
SIO CAPITAL MANAGEMENT, LLC1.25%2.62%535,741535,741100.00%8,786,152Mar 31, 2024
KYNAM CAPITAL MANAGEMENT, LP1.20%0.88%515,190175,00051.44%8,449,116Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC0.97%0.00%416,80883,33924.99%6,837,116Mar 31, 2024
FIRST TURN MANAGEMENT, LLC0.89%0.94%381,210381,210100.00%6,251,844Mar 31, 2024
JPMORGAN CHASE & CO0.89%0.00%380,597-21,109-5.25%6,241,791Mar 31, 2024
STATE STREET CORP0.68%0.00%292,23426,88010.13%4,792,638Mar 31, 2024

Tyra Biosciences's largest institutional shareholder is RA CAPITAL MANAGEMENT, L.P., holding 24.24% of the company's total share outstanding, currently valued at $170.83M. The top 10 institutional shareholders own together 91.55% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CANAAN PARTNERS XI LLC10.26%79.77%4,409,991--72,323,852Mar 31, 2024
NEXTECH INVEST LTD.9.44%10.54%4,055,8611,537,27961.04%66,516,120Mar 31, 2024
BOXER CAPITAL, LLC15.01%5.22%6,448,359--105,753,088Mar 31, 2024
5AM VENTURE MANAGEMENT, LLC2.19%3.45%939,298384,31969.25%15,404,487Mar 31, 2024
SIO CAPITAL MANAGEMENT, LLC1.25%2.62%535,741535,741100.00%8,786,152Mar 31, 2024
TCG CROSSOVER MANAGEMENT, LLC4.63%2.58%1,989,103--32,621,289Mar 31, 2024
FAIRMOUNT FUNDS MANAGEMENT LLC3.24%2.49%1,393,329--22,850,596Mar 31, 2024
BVF INC/IL10.85%2.10%4,661,1941,921,59970.14%76,443,582Mar 31, 2024
FIRST TURN MANAGEMENT, LLC0.89%0.94%381,210381,210100.00%6,251,844Mar 31, 2024
KYNAM CAPITAL MANAGEMENT, LP1.20%0.88%515,190175,00051.44%8,449,116Mar 31, 2024
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.1.94%0.58%832,220-194,200-18.92%13,648,408Mar 31, 2024
AUOUR INVESTMENTS LLC0.20%0.51%85,020--1,394,328Mar 31, 2024
NICHOLAS INVESTMENT PARTNERS, LP0.36%0.26%152,968152,968100.00%2,508,675Mar 31, 2024
RA CAPITAL MANAGEMENT, L.P.24.24%0.25%10,416,6093,180,15543.95%170,832,388Mar 31, 2024
ORBIMED ADVISORS LLC1.79%0.23%768,638768,638100.00%12,605,663Mar 31, 2024
PERCEPTIVE ADVISORS LLC1.56%0.19%669,159309,15985.88%10,974,208Mar 31, 2024
ADAR1 CAPITAL MANAGEMENT, LLC0.07%0.11%28,30028,300100.00%464,120Mar 31, 2024
LEGATO CAPITAL MANAGEMENT LLC0.05%0.04%20,25920,259100.00%332,248Mar 31, 2024
EXODUSPOINT CAPITAL MANAGEMENT, LP0.63%0.03%272,150272,150100.00%4,463,000Mar 31, 2024
DRIEHAUS CAPITAL MANAGEMENT LLC0.47%0.03%203,709--3,340,828Mar 31, 2024

The largest Tyra Biosciences shareholder by % of total assets is CANAAN PARTNERS XI LLC. The company owns 4.41M shares of Tyra Biosciences (TYRA), representing 79.77% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
RA CAPITAL MANAGEMENT, L.P.24.24%0.25%10,416,6093,180,15543.95%170,832,388Mar 31, 2024
BVF INC/IL10.85%2.10%4,661,1941,921,59970.14%76,443,582Mar 31, 2024
NEXTECH INVEST LTD.9.44%10.54%4,055,8611,537,27961.04%66,516,120Mar 31, 2024
FMR LLC9.26%0.00%3,977,2081,208,51243.65%65,226,211Mar 31, 2024
ORBIMED ADVISORS LLC1.79%0.23%768,638768,638100.00%12,605,663Mar 31, 2024
SIO CAPITAL MANAGEMENT, LLC1.25%2.62%535,741535,741100.00%8,786,152Mar 31, 2024
5AM VENTURE MANAGEMENT, LLC2.19%3.45%939,298384,31969.25%15,404,487Mar 31, 2024
FIRST TURN MANAGEMENT, LLC0.89%0.94%381,210381,210100.00%6,251,844Mar 31, 2024
PERCEPTIVE ADVISORS LLC1.56%0.19%669,159309,15985.88%10,974,208Mar 31, 2024
EXODUSPOINT CAPITAL MANAGEMENT, LP0.63%0.03%272,150272,150100.00%4,463,000Mar 31, 2024
KYNAM CAPITAL MANAGEMENT, LP1.20%0.88%515,190175,00051.44%8,449,116Mar 31, 2024
NICHOLAS INVESTMENT PARTNERS, LP0.36%0.26%152,968152,968100.00%2,508,675Mar 31, 2024
VANGUARD GROUP INC2.09%0.00%899,800140,83318.56%14,756,720Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC0.97%0.00%416,80883,33924.99%6,837,116Mar 31, 2024
BLACKROCK INC.2.43%0.00%1,044,22579,1918.21%17,125,289Mar 31, 2024
OPPENHEIMER & CO INC0.14%0.02%59,57659,576100.00%977,046Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC0.13%0.00%54,40054,400100.00%892,000Mar 31, 2024
TWO SIGMA INVESTMENTS, LP0.10%0.00%41,74241,742100.00%684,569Mar 31, 2024
CHARLES SCHWAB INVESTMENT MANAGEMENT INC0.35%0.00%152,21241,67537.70%2,496,277Mar 31, 2024
ADAR1 CAPITAL MANAGEMENT, LLC0.07%0.11%28,30028,300100.00%464,120Mar 31, 2024

As of Mar 31 2024, Tyra Biosciences's largest institutional buyer is RA CAPITAL MANAGEMENT, L.P.. The company purchased 3.18M stocks of TYRA, valued at $170.83M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.1.94%0.58%832,220-194,200-18.92%13,648,408Mar 31, 2024
ECOR1 CAPITAL, LLC----137,014-100.00%-Mar 31, 2024
IKARIAN CAPITAL, LLC0.00%0.00%501-47,669-98.96%8,216Mar 31, 2024
MARINER, LLC----22,164-100.00%-Mar 31, 2024
JPMORGAN CHASE & CO0.89%0.00%380,597-21,109-5.25%6,241,791Mar 31, 2024
BELVEDERE TRADING LLC----14,400-100.00%-Mar 31, 2024
SEPIO CAPITAL, LP----10,625-100.00%-Mar 31, 2024
LPL FINANCIAL LLC----10,500-100.00%-Mar 31, 2024
MARSHALL WACE, LLP0.05%0.00%19,643-10,358-34.53%322,145Mar 31, 2024
ARTIA GLOBAL PARTNERS LP----10,253-100.00%-Mar 31, 2024
BARCLAYS PLC0.02%0.00%9,850-9,377-48.77%161,000Mar 31, 2024
ACUTA CAPITAL PARTNERS, LLC----8,867-100.00%-Mar 31, 2024
AJOVISTA, LLC----4,235-100.00%-Mar 31, 2024
ROYAL BANK OF CANADA0.00%-320-3,924-92.46%5,000Mar 31, 2024
VICTORY CAPITAL MANAGEMENT INC0.11%0.00%48,090-2,130-4.24%788,676Mar 31, 2024
FEDERATED HERMES, INC.0.00%-713-1,357-65.56%11,693Mar 31, 2024
AMALGAMATED BANK0.00%0.00%424-1,021-70.66%7,000Mar 31, 2024
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM0.00%-1,406-896-38.92%23,058Mar 31, 2024
TOWER RESEARCH CAPITAL LLC (TRC)0.00%0.00%144-860-85.66%2,362Mar 31, 2024
WELLINGTON MANAGEMENT GROUP LLP0.24%0.00%101,788-648-0.63%1,669,324Mar 31, 2024

As of Mar 31 2024, Tyra Biosciences's biggest institutional seller is FRAZIER LIFE SCIENCES MANAGEMENT, L.P.. The company sold -0.19M shares of TYRA, valued at $13.65M.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ORBIMED ADVISORS LLC1.79%0.23%768,638768,638100.00%12,605,663Mar 31, 2024
SIO CAPITAL MANAGEMENT, LLC1.25%2.62%535,741535,741100.00%8,786,152Mar 31, 2024
FIRST TURN MANAGEMENT, LLC0.89%0.94%381,210381,210100.00%6,251,844Mar 31, 2024
EXODUSPOINT CAPITAL MANAGEMENT, LP0.63%0.03%272,150272,150100.00%4,463,000Mar 31, 2024
NICHOLAS INVESTMENT PARTNERS, LP0.36%0.26%152,968152,968100.00%2,508,675Mar 31, 2024
OPPENHEIMER & CO INC0.14%0.02%59,57659,576100.00%977,046Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC0.13%0.00%54,40054,400100.00%892,000Mar 31, 2024
TWO SIGMA INVESTMENTS, LP0.10%0.00%41,74241,742100.00%684,569Mar 31, 2024
ADAR1 CAPITAL MANAGEMENT, LLC0.07%0.11%28,30028,300100.00%464,120Mar 31, 2024
LEGATO CAPITAL MANAGEMENT LLC0.05%0.04%20,25920,259100.00%332,248Mar 31, 2024
WALLEYE CAPITAL LLC0.04%0.00%16,88716,887100.00%276,947Mar 31, 2024
CITADEL ADVISORS LLC0.04%0.00%16,78916,789100.00%275,340Mar 31, 2024
JUMP FINANCIAL, LLC0.04%0.01%15,15915,159100.00%248,607Mar 31, 2024
FISHMAN JAY A LTD/MI0.03%0.03%15,00015,000100.00%246,000Mar 31, 2024
GOLDMAN SACHS GROUP INC0.03%-14,07714,077100.00%230,863Mar 31, 2024
HUDSON BAY CAPITAL MANAGEMENT LP0.03%0.00%13,31713,317100.00%218,399Mar 31, 2024
PDT PARTNERS, LLC0.03%0.02%12,17412,174100.00%199,654Mar 31, 2024
CITADEL ADVISORS LLC0.01%-3,7003,700100.00%60,680Mar 31, 2024
ENTRYPOINT CAPITAL, LLC0.00%0.02%1,3451,345100.00%22,058Mar 31, 2024
STRS OHIO0.00%-700700100.00%11,000Mar 31, 2024
CITADEL ADVISORS LLC0.00%-600600100.00%9,840Mar 31, 2024
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC--22100.00%32Mar 31, 2024

Tyra Biosciences's largest new institutional shareholder by number of shares is ORBIMED ADVISORS LLC, purchased 768.64K shares, valued at $12.61M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ECOR1 CAPITAL, LLC----137,014-100.00%-Mar 31, 2024
MARINER, LLC----22,164-100.00%-Mar 31, 2024
BELVEDERE TRADING LLC----14,400-100.00%-Mar 31, 2024
SEPIO CAPITAL, LP----10,625-100.00%-Mar 31, 2024
LPL FINANCIAL LLC----10,500-100.00%-Mar 31, 2024
ARTIA GLOBAL PARTNERS LP----10,253-100.00%-Mar 31, 2024
ACUTA CAPITAL PARTNERS, LLC----8,867-100.00%-Mar 31, 2024
AJOVISTA, LLC----4,235-100.00%-Mar 31, 2024

Tyra Biosciences's largest sold out institutional shareholder by shares sold is ECOR1 CAPITAL, LLC, sold -0.14M shares, valued at -, as of undefined.

Tyra Biosciences Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
FIDELITY ADVISOR SERIES VII0.07%604,900308,300103.94%Jan 31, 2024
FIDELITY CAPITAL TRUST0.04%419,4437,6001.85%Jan 31, 2024
VANGUARD VALLEY FORGE FUNDS0.03%12,400--Dec 31, 2023
Vericimetry Funds0.02%2,640--Dec 31, 2023
FIDELITY SECURITIES FUND0.02%1,839,248153,9019.13%Jan 31, 2024
FIDELITY COMMONWEALTH TRUST0.01%20,5875,36035.20%Feb 29, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.00%2,162--Dec 31, 2023
QUANTITATIVE MASTER SERIES LLC0.00%24,587--Dec 31, 2023
VANGUARD INDEX FUNDS0.00%866,984281,80448.16%Dec 31, 2023
FIDELITY MT VERNON STREET TRUST0.00%50,705--Feb 29, 2024
FIDELITY SELECT PORTFOLIOS0.00%76,100-33,800-30.76%Feb 29, 2024
FIDELITY ADVISOR SERIES I0.00%212,000-186,000-46.73%Feb 29, 2024
FIDELITY COVINGTON TRUST0.00%15,9077,60091.49%Feb 29, 2024
VICTORY PORTFOLIOS0.00%33,06011,12050.68%Dec 31, 2023
FIDELITY CONCORD STREET TRUST0.00%157,15010,3807.07%Feb 29, 2024
Voya INVESTORS TRUST0.00%36,093-1,664-4.41%Dec 31, 2023
ETF Series Solutions0.00%11,2121,79519.06%Feb 29, 2024
SEASONS SERIES TRUST0.00%11,823-221-1.83%Dec 31, 2023
SCHWAB STRATEGIC TRUST0.00%76,6864790.63%Feb 29, 2024
Calvert Variable Products, Inc.0.00%940--Dec 31, 2023
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%7,492--Dec 31, 2023
GOLDMAN SACHS VARIABLE INSURANCE TRUST0.00%850--Dec 31, 2023
Federated Hermes Global Allocation Fund0.00%2,1421,585284.56%Feb 29, 2024
Voya VARIABLE PORTFOLIOS INC0.00%5,884--Dec 31, 2023
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%664--Dec 31, 2023
TIAA-CREF LIFE FUNDS0.00%356--Dec 31, 2023
AMERICAN CENTURY ETF TRUST0.00%12,1552,61027.34%Feb 29, 2024
Goldman Sachs ETF Trust0.00%7,5957,595-Feb 29, 2024
VARIABLE INSURANCE PRODUCTS FUND II0.00%698--Dec 31, 2023
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%4,207--Dec 31, 2023
T. Rowe Price Index Trust, Inc.0.00%706--Feb 29, 2024
NORTHERN FUNDS0.00%28,737--Dec 29, 2023
VANGUARD SCOTTSDALE FUNDS0.00%61,8277,01612.80%Feb 29, 2024
RYDEX SERIES FUNDS0.00%127--Dec 31, 2023
EQ ADVISORS TRUST0.00%34,6962630.76%Dec 31, 2023
ProFunds0.00%2008269.49%Jan 31, 2024
VALIC Co I0.00%5,367-22-0.41%Feb 29, 2024
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST0.00%40,6485741.43%Dec 31, 2023
PENN SERIES FUNDS INC0.00%500--Dec 29, 2023
NATIONWIDE VARIABLE INSURANCE TRUST0.00%2,120--Dec 31, 2023
RYDEX DYNAMIC FUNDS0.00%63--Dec 31, 2023
NATIONWIDE MUTUAL FUNDS0.00%1,566-10-0.63%Jan 31, 2024
Guggenheim Active Allocation Fund0.00%70--Feb 29, 2024
PROSHARES TRUST0.00%2,04826014.54%Feb 29, 2024
RYDEX VARIABLE TRUST0.00%8--Dec 31, 2023
COLLEGE RETIREMENT EQUITIES FUND0.00%6,957--Dec 31, 2023
MORGAN STANLEY PATHWAY FUNDS0.00%599--Feb 29, 2024
DFA INVESTMENT DIMENSIONS GROUP INC0.00%5,4891,70144.90%Jan 31, 2024
SUNAMERICA SERIES TRUST0.00%1,584-7-0.44%Jan 31, 2024
Brinker Capital Destinations Trust0.00%256--Feb 29, 2024
Advisors' Inner Circle Fund III0.00%591431.11%Jan 31, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST0.00%6,341--Dec 31, 2023
Brighthouse Funds Trust II0.00%4,942--Dec 31, 2023
PACIFIC SELECT FUND0.00%5,340-195-3.52%Dec 31, 2023
MASSMUTUAL SELECT FUNDS0.00%979--Dec 31, 2023
Bridge Builder Trust0.00%4,419--Dec 31, 2023
BlackRock Variable Series Funds, Inc.0.00%1,546--Dec 31, 2023
SEI INSTITUTIONAL INVESTMENTS TRUST0.00%2,600--Feb 29, 2024

Tyra Biosciences's largest mutual fund holder by % of total assets is "FIDELITY ADVISOR SERIES VII", owning 604.90K shares, compromising 0.07% of its total assets.

Tyra Biosciences Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 2425-60.32%
31 Dec, 23638.62%
30 Sep, 2358-1.69%
30 Jun, 235913.46%
31 Mar, 235210.64%
31 Dec, 2247-
30 Sep, 22476.82%
30 Jun, 2244-4.35%
31 Mar, 22462.22%
31 Dec, 214573.08%
30 Sep, 2126-

As of 31 Mar 24, 25 institutions are holding Tyra Biosciences's shares, representing a decrease of -60.32% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 247,632,256-78.66%
31 Dec, 2335,756,693-1.90%
30 Sep, 2336,450,7610.66%
30 Jun, 2336,210,8091.53%
31 Mar, 2335,666,0241.21%
31 Dec, 2235,239,879-1.27%
30 Sep, 2235,693,315-0.10%
30 Jun, 2235,727,755-1.12%
31 Mar, 2236,133,9762.73%
31 Dec, 2135,174,36734.87%
30 Sep, 2126,080,764-

Tyra Biosciences (TYRA) has 7.63M shares outstanding as of 31 Mar 24, down -78.66% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 2417.76%0.26%
31 Dec, 2383.41%1.14%
30 Sep, 2385.59%1.17%
30 Jun, 2385.41%1.21%
31 Mar, 2384.13%1.19%
31 Dec, 2284.14%1.16%
30 Sep, 2284.99%1.16%
30 Jun, 2285.52%1.13%
31 Mar, 2286.96%1.20%
31 Dec, 2185.16%2.14%
30 Sep, 2163.14%-

As of 31 Mar 24, Tyra Biosciences is held by 17.76% institutional shareholders, representing a 0.26% growth compared to 31 Dec 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 2417-45.16%
31 Dec, 233163.16%
30 Sep, 2319-32.14%
30 Jun, 2328-
31 Mar, 232864.71%
31 Dec, 2217-15.00%
30 Sep, 2220-
30 Jun, 22205.26%
31 Mar, 2219-45.71%
31 Dec, 213534.62%
30 Sep, 2126-

17 institutional shareholders have increased their position in TYRA stock as of 31 Mar 24 compared to 31 in the previous quarter (a -45.16% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 244-66.67%
31 Dec, 2312-25.00%
30 Sep, 231614.29%
30 Jun, 231455.56%
31 Mar, 239-18.18%
31 Dec, 2211-26.67%
30 Sep, 2215-6.25%
30 Jun, 2216-15.79%
31 Mar, 2219171.43%
31 Dec, 217-
30 Sep, 21--

4 institutional shareholders have reduced their position in TYRA stock as of 31 Mar 24 compared to 12 in the previous quarter (a -66.67% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 2425-60.32%7,632,256-78.66%17.76%0.26%17-45.16%4-66.67%
31 Dec, 23638.62%35,756,693-1.90%83.41%1.14%3163.16%12-25.00%
30 Sep, 2358-1.69%36,450,7610.66%85.59%1.17%19-32.14%1614.29%
30 Jun, 235913.46%36,210,8091.53%85.41%1.21%28-1455.56%
31 Mar, 235210.64%35,666,0241.21%84.13%1.19%2864.71%9-18.18%
31 Dec, 2247-35,239,879-1.27%84.14%1.16%17-15.00%11-26.67%
30 Sep, 22476.82%35,693,315-0.10%84.99%1.16%20-15-6.25%
30 Jun, 2244-4.35%35,727,755-1.12%85.52%1.13%205.26%16-15.79%
31 Mar, 22462.22%36,133,9762.73%86.96%1.20%19-45.71%19171.43%
31 Dec, 214573.08%35,174,36734.87%85.16%2.14%3534.62%7-
30 Sep, 2126-26,080,764-63.14%-26---

Tyra Biosciences Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Mar 13, 2024Bensen Danielofficer Chief Operating OfficerS-SaleSell200$20.00$4.00K431,683
Mar 08, 2024Bensen Danielofficer Chief Operating OfficerS-SaleSell1,733$20.09$34.82K431,951
Mar 08, 2024Bensen Danielofficer Chief Operating OfficerS-SaleSell68$20.00$1.36K431,883
Mar 05, 2024Bensen Danielofficer Chief Operating OfficerS-SaleSell2,900$20.04$58.11K439,936
Mar 05, 2024Bensen Danielofficer Chief Operating OfficerS-SaleSell5,063$20.08$101.65K434,873
Mar 05, 2024Bensen Danielofficer Chief Operating OfficerS-SaleSell1,189$20.02$23.80K433,684
Feb 29, 2024Bensen Danielofficer Chief Operating OfficerS-SaleSell745$20.00$14.90K450,735
Feb 29, 2024Bensen Danielofficer Chief Operating OfficerS-SaleSell5,849$20.13$117.73K444,886
Feb 29, 2024Bensen Danielofficer Chief Operating OfficerS-SaleSell2,050$20.00$41.00K442,836
Feb 14, 2024Bensen Danielofficer Chief Operating OfficerS-SaleSell1,501$20.00$30.02K451,480
Feb 09, 2024Bensen Danielofficer Chief Operating OfficerS-SaleSell9,587$18.09$173.47K452,981

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 09, 2024Moran Susandirector-Sell----
May 09, 2024Rothenberg Stephen Michaeldirector-Sell----
Mar 13, 2024Bensen Danielofficer Chief Operating OfficerS-SaleSell200$20.00$4.00K431,683
Mar 08, 2024Bensen Danielofficer Chief Operating OfficerS-SaleSell1,733$20.09$34.82K431,951
Mar 08, 2024Bensen Danielofficer Chief Operating OfficerS-SaleSell68$20.00$1.36K431,883
Mar 05, 2024Bensen Danielofficer Chief Operating OfficerS-SaleSell2,900$20.04$58.11K439,936
Mar 05, 2024Bensen Danielofficer Chief Operating OfficerS-SaleSell5,063$20.08$101.65K434,873
Mar 05, 2024Bensen Danielofficer Chief Operating OfficerS-SaleSell1,189$20.02$23.80K433,684
Feb 29, 2024Bensen Danielofficer Chief Operating OfficerS-SaleSell745$20.00$14.90K450,735
Feb 29, 2024Bensen Danielofficer Chief Operating OfficerS-SaleSell5,849$20.13$117.73K444,886
Feb 29, 2024Bensen Danielofficer Chief Operating OfficerS-SaleSell2,050$20.00$41.00K442,836
Feb 14, 2024Bensen Danielofficer Chief Operating OfficerS-SaleSell1,501$20.00$30.02K451,480
Feb 09, 2024Bensen Danielofficer Chief Operating OfficerS-SaleSell9,587$18.09$173.47K452,981

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 09, 2024Moran Susandirector-A-AwardBuy37,200$17.94$667.37K37,200
May 09, 2024Moran Susandirector-Sell----
May 09, 2024Rothenberg Stephen Michaeldirector-A-AwardBuy37,200$17.94$667.37K37,200
May 09, 2024Rothenberg Stephen Michaeldirector-Sell----
Mar 19, 2024Fuhrman Alanofficer Chief Financial OfficerA-AwardBuy932$12.48$11.63K2,395
Mar 19, 2024Tada Hiroomiofficer Chief Medical OfficerA-AwardBuy1,968$6.58$12.95K86,435
Mar 19, 2024Harris Todddirector, officer President and CEOA-AwardBuy1,880$6.58$12.37K1,504,577
Mar 13, 2024Bensen Danielofficer Chief Operating OfficerS-SaleSell200$20.00$4.00K431,683
Mar 08, 2024Bensen Danielofficer Chief Operating OfficerS-SaleSell1,733$20.09$34.82K431,951
Mar 08, 2024Bensen Danielofficer Chief Operating OfficerS-SaleSell68$20.00$1.36K431,883
Mar 05, 2024Bensen Danielofficer Chief Operating OfficerS-SaleSell2,900$20.04$58.11K439,936
Mar 05, 2024Bensen Danielofficer Chief Operating OfficerS-SaleSell5,063$20.08$101.65K434,873
Mar 05, 2024Bensen Danielofficer Chief Operating OfficerS-SaleSell1,189$20.02$23.80K433,684
Feb 29, 2024Bensen Danielofficer Chief Operating OfficerS-SaleSell745$20.00$14.90K450,735
Feb 29, 2024Bensen Danielofficer Chief Operating OfficerS-SaleSell5,849$20.13$117.73K444,886
Feb 29, 2024Bensen Danielofficer Chief Operating OfficerS-SaleSell2,050$20.00$41.00K442,836
Feb 14, 2024Bensen Danielofficer Chief Operating OfficerS-SaleSell1,501$20.00$30.02K451,480
Feb 09, 2024Bensen Danielofficer Chief Operating OfficerS-SaleSell9,587$18.09$173.47K452,981
Feb 08, 2024RA CAPITAL MANAGEMENT, L.P.director, 10 percent owner A-AwardBuy3,180,155$13.01$41.37M8,477,275
Feb 08, 2024RA CAPITAL MANAGEMENT, L.P.director, 10 percent owner A-AwardBuy1,538,457-$1.54K1,538,457

The last insider sell of Tyra Biosciences's stock was made by Moran Susan on May 09 2024, selling - shares at - per share (valued at -).

Tyra Biosciences Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 202422100.00%
Q1 202481844.44%
Q3 2023151788.24%
Q2 2023203754.05%
Q1 2023203066.67%
Q4 2022-1-
Q3 202211--
Q2 202212--
Q1 2022-3-
Q4 202115--
Q3 2021235046.00%

2 total buy trades, and 2 total sell trades (buy/sell ratio of 1.00%) were made by Tyra Biosciences's insiders, as of Q2 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024---
Q1 2024-17-
Q3 2023-9-
Q2 2023-25-
Q1 2023-12-
Q4 2022---
Q3 2022---
Q2 2022---
Q1 2022---
Q4 20211--
Q3 20215--

As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Tyra Biosciences's stocks.

Tyra Biosciences Peer Ownership


TickerCompany
MLYSMineralys Therapeutics, Inc.
GRCLGracell Biotechnologies Inc.
PMVPPMV Pharmaceuticals, Inc.
DSGNDesign Therapeutics, Inc.
CCCCC4 Therapeutics, Inc.
STOKStoke Therapeutics, Inc.
IPSCCentury Therapeutics, Inc.
EWTXEdgewise Therapeutics, Inc.
HOWLWerewolf Therapeutics, Inc.
ERASErasca, Inc.
CGEMCullinan Oncology, Inc.
GLUEMonte Rosa Therapeutics, Inc.
PHVSPharvaris N.V.
CNTBConnect Biopharma Holdings Limited
IKNAIkena Oncology, Inc.
XLOXilio Therapeutics, Inc.
MOLNMolecular Partners AG
RAPTRAPT Therapeutics, Inc.

TYRA Ownership FAQ


Tyra Biosciences is owned by institutional shareholders (17.76%), insiders (5.33%), and public (76.90%). The largest institutional shareholder of Tyra Biosciences is RA CAPITAL MANAGEMENT, L.P. (24.24% of total shares) and the top mutual fund owner is FIDELITY ADVISOR SERIES VII (0.07% of total shares).

Tyra Biosciences's major institutional shareholders are RA CAPITAL MANAGEMENT, L.P., BOXER CAPITAL, LLC, BVF INC/IL, CANAAN PARTNERS XI LLC, and NEXTECH INVEST LTD.. The top five shareholders own together 69.80% of the company's share outstanding.

As of Mar 2024, there are 25 institutional shareholders of Tyra Biosciences.

RA CAPITAL MANAGEMENT, L.P owns 10.42M shares of Tyra Biosciences, representing 24.24% of the company's total shares outstanding, valued at $170.83M (as of Mar 2024).

As of Mar 2024, BOXER CAPITAL, LLC holds 6.45M shares of Tyra Biosciences (TYRA), compromising 15.01% of the company, valued at $105.75M.

BVF INC/IL is the third largest holder of Tyra Biosciences. The company owns 4.66M of the company's shares outstanding (worth $76.44M).